Dr. Matloubian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
# Plaza
San Francisco, CA 94143Phone+1 415-353-2497Fax+1 415-353-2777
Education & Training
- University of California (San Francisco)Fellowship, Rheumatology, 1998 - 2001
- University of California (San Francisco)Residency, Internal Medicine, 1996 - 1998
- David Geffen School of Medicine at UCLAClass of 1996
Certifications & Licensure
- CA State Medical License 1998 - 2026
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2010
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 3 citationsUsing the technology acceptance model to assess clinician perceptions and experiences with a rheumatoid arthritis outcomes dashboard: qualitative study.Catherine Nasrallah, Cherish Wilson, Alicia Hamblin, Cammie Young, Lindsay Jacobsohn
BMC Medical Informatics and Decision Making. 2024-05-27 - Complement Factor I Gene Variant as a Treatable Cause of Recurrent Aseptic Neutrophilic Meningitis: A Case Report.Mary Rolfes, Adil Harroud, Kelsey C Zorn, Asritha Tubati, Charles Omura
Neurology(R) Neuroimmunology & Neuroinflammation. 2023-09-01 - 1 citationsSleep Disturbance and SARS-CoV-2 Vaccinations in Patients With Chronic Inflammatory Disease.Niti Pawar, Kimberly E Taylor, Monica Yang, Parakkal Deepak, Wooseob Kim
Arthritis Care & Research. 2023-08-01
Press Mentions
- I Have an Array of Autoimmune Conditions. How Much Will the COVID Vaccine Protect Me?April 12th, 2021
- Today’s Top News Highlights: COVID-19 Vaccine Hurdles, New Options in Prostate CancerMay 21st, 2020
Grant Support
- Regulation Of Lymphocyte Trafficking By S1P1 And CD69National Institute Of Allergy And Infectious Diseases2008–2011
- Molecular And Cellular Regulation Of Lymphocyte Exit By InterferonNational Institute Of Allergy And Infectious Diseases2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: